Unprecedented growth at a CAGR of 39.6% positions CAR T-cell therapy as a transformative force in oncologyDelray Beach, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) — The global CAR T-cell Therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 39.6% from 2024 to 2029, culminating in a forecasted valuation of US$29.0 billion by the end of the period. This rapid acceleration underscores the convergence of critical factors: escalaRead More
Global CAR T-Cell Therapy Market Set to Reach USD 29 Billion by 2029
